Cue Biopharma director Aaron Fletcher resigns from board effective Oct 9, 2023

Cue Biopharma, Inc.

Aaron Fletcher notified Cue Biopharma of resignation from Board and all committees.
Resignation effective October 9, 2023, is not due to any disagreement with the Company.
No replacement or successor named; board size adjusted.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Aaron Fletcher

Member of the Board of Directors

CUE · Cue Biopharma, Inc.

Effective: 2023-10-09
Filed: September 14, 2023, 7:59 PM ET

On September 12, 2023, Aaron Fletcher notified Cue Biopharma, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company (the “Board”) and all committees thereof, effective on October 9, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Aaron Fletcher resigned as Member of the Board of Directors at Cue Biopharma, Inc..

Action: resigned
Role: Member of the Board of Directors

Exact text from the filing

On September 12, 2023, Aaron Fletcher notified Cue Biopharma, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company (the “Board”) and all committees thereof, effective on October 9, 2023.

View on SEC.gov

Cue Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-235298

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.